United States · Funded startup

Who invested in ACT Biotech

5 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow ACT Biotech and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$26Mraised across 5 rounds since 2008, from 5 sources

$6.6MSeries A$6.2MSeries A$12MSeries A

Latest round: Debt, $1.0MMay 2010
Biggest round: $12MSeries A · Mar 2009
Step-upi: 2×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20092010

$6.6MSeries A$6.2MSeries A$12MSeries A$500KVenture$1.0MDebt

First round: Series A, $6.6M
Biggest round: $12M
Usual gap between rounds: 7 months

The rounds

May 2010
Debt$1.0M
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale Apr 2010
Oct 2009
Venture$500K
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Sept 2009
Mar 2009
Series A$12M
No investor was named in the report.
Reported by sec.gov
Sept 2008
Series A$6.2M
No investor was named in the report.
Reported by sec.gov
May 2008
Series A$6.6M1 new
- NGN Capital
Reported by sec.gov

Funding filed with regulators

ACT Biotech filed 3 raises, $2.5M in all. Filings say how much was sold and to how many investors; they never name the investors.

Jun 2010$1.0M1 investordebt, options, securities on exerciseof $4.0M offeredSEC Form D
Apr 2010$1.0M1 investordebt, optionsof $2.0M offeredSEC Form D
Sept 2009$500K1 investorequitySEC Form D